291,666 Shares in Artiva Biotherapeutics, Inc. Purchased by Samsara BioCapital LLC - MarketBeat
| ARTV Stock | 10.40 0.22 2.07% |
Slightly above 55% of Artiva Biotherapeutics,'s sophisticated investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Artiva Biotherapeutics, Common suggests that some traders are interested. Artiva Biotherapeutics,'s investing sentiment can be driven by a variety of factors including economic data, Artiva Biotherapeutics,'s earnings reports, geopolitical events, and overall market trends.
Artiva |
291,666 Shares in Artiva Biotherapeutics, Inc. Purchased by Samsara BioCapital LLC MarketBeat
Read at news.google.com
 |
Artiva Biotherapeutics, Fundamental Analysis
We analyze Artiva Biotherapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Artiva Biotherapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Artiva Biotherapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Artiva Biotherapeutics, is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Artiva Biotherapeutics, Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Artiva Biotherapeutics, stock to make a market-neutral strategy. Peer analysis of Artiva Biotherapeutics, could also be used in its relative valuation, which is a method of valuing Artiva Biotherapeutics, by comparing valuation metrics with similar companies.
Peers
Artiva Biotherapeutics, Related Equities
| CHD | Church Dwight | 0.00 |
| ||
| LECO | Lincoln Electric | 0.03 |
| ||
| FSP | Franklin Street | 0.48 |
| ||
| UL | Unilever PLC | 1.20 |
| ||
| EWCZ | European Wax | 1.72 |
| ||
| ACU | Acme United | 1.79 |
| ||
| ATEX | Anterix | 2.60 |
|
Additional Tools for Artiva Stock Analysis
When running Artiva Biotherapeutics,'s price analysis, check to measure Artiva Biotherapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artiva Biotherapeutics, is operating at the current time. Most of Artiva Biotherapeutics,'s value examination focuses on studying past and present price action to predict the probability of Artiva Biotherapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artiva Biotherapeutics,'s price. Additionally, you may evaluate how the addition of Artiva Biotherapeutics, to your portfolios can decrease your overall portfolio volatility.